share_log

Aditxt | PRER14A: Preliminary revised proxy soliciting materials

Aditxt | PRER14A: Preliminary revised proxy soliciting materials

Aditxt | PRER14A：初步修订代理权征集材料
美股SEC公告 ·  2024/06/08 05:17

Moomoo AI 已提取核心信息

Aditxt, Inc. has scheduled its Annual Meeting for July 10, 2024, where stockholders are invited to attend virtually to vote on several key proposals. The agenda includes the election of five board members and the ratification of dbbmckennon as the independent auditor for the upcoming fiscal year. Additionally, stockholders will vote on the approval of common stock issuance related to Series A-1, B-1, and B-2 Convertible Preferred Stock, all issued between December 2023 and January 2024. Another significant proposal is the approval of common stock issuance under the company's equity line of credit agreement, with a maximum purchase price of $150 million. The company also seeks to increase the authorized shares of common stock from 100 million to 1 billion and to grant the board discretionary authority to effect a reverse stock split. Furthermore, an amendment to increase the number of shares issuable under the 2021 Omnibus Equity Incentive Plan to 500,000 shares will be considered. Lastly, stockholders will vote on authorizing the adjournment of the Annual Meeting if necessary to solicit additional proxies.
Aditxt, Inc. has scheduled its Annual Meeting for July 10, 2024, where stockholders are invited to attend virtually to vote on several key proposals. The agenda includes the election of five board members and the ratification of dbbmckennon as the independent auditor for the upcoming fiscal year. Additionally, stockholders will vote on the approval of common stock issuance related to Series A-1, B-1, and B-2 Convertible Preferred Stock, all issued between December 2023 and January 2024. Another significant proposal is the approval of common stock issuance under the company's equity line of credit agreement, with a maximum purchase price of $150 million. The company also seeks to increase the authorized shares of common stock from 100 million to 1 billion and to grant the board discretionary authority to effect a reverse stock split. Furthermore, an amendment to increase the number of shares issuable under the 2021 Omnibus Equity Incentive Plan to 500,000 shares will be considered. Lastly, stockholders will vote on authorizing the adjournment of the Annual Meeting if necessary to solicit additional proxies.
Aditxt公司已经安排了2024年7月10日的年度会议，股东们被邀请通过虚拟参加并就几项关键提案进行投票。议程包括选举五名董事会成员，确认dbbmckennon为未来财政年度的独立审计师。此外，股东还将就与Series A-1、B-1和B-2可转换优先股相关的普通股发行批准进行投票，这些股票的发行时间为2023年12月至2024年1月。另一个重要提案是批准公司根据其股权授信协议发行普通股，最高购买价为1.5亿美元。公司还寻求将普通股的授权股份从1亿增加到10亿，并授予董事会裁量权以实施一次反向股票拆分。此外，还将考虑一项修正案，以将2021年股票期权激励计划可发行股票数量增加到50万股。最后，股东将就必要时授权推迟年度会议以征求更多委托的提案进行投票。
Aditxt公司已经安排了2024年7月10日的年度会议，股东们被邀请通过虚拟参加并就几项关键提案进行投票。议程包括选举五名董事会成员，确认dbbmckennon为未来财政年度的独立审计师。此外，股东还将就与Series A-1、B-1和B-2可转换优先股相关的普通股发行批准进行投票，这些股票的发行时间为2023年12月至2024年1月。另一个重要提案是批准公司根据其股权授信协议发行普通股，最高购买价为1.5亿美元。公司还寻求将普通股的授权股份从1亿增加到10亿，并授予董事会裁量权以实施一次反向股票拆分。此外，还将考虑一项修正案，以将2021年股票期权激励计划可发行股票数量增加到50万股。最后，股东将就必要时授权推迟年度会议以征求更多委托的提案进行投票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Evaxion Biotech
    EVAX
    -- 6.030
    PMGC Holdings
    ELAB
    -- 3.100
    Lantern Pharma
    LTRN
    -- 5.400
    Transcode Therapeutics
    RNAZ
    -- 7.040
    Neuphoria Therapeutics
    NEUP
    -- 4.390
    解锁完整榜单
    热门讨论
    特朗普2.0时代开启，全球股市新风口在哪里？
    ▪️加密货币政策能否利好crypto？ ▪️关税政策能否利好中概等海外资产？ ▪️在特朗普政策下，有哪些投资机会值得关注？ 展开
    离川普上台只有7天了～
    热门中概股
    追踪最热门的中概股实时资讯。